Civil Rights Attorney's Fees Award Act of 1976

Consumers Who Purchased CVS-Brand Maximum Strength Lidocaine Products Could Get Money from a Settlement

Retrieved on: 
Tuesday, August 22, 2023
Online, Unit, Defendant, Exclusion, Bell, Pharmacy, CM/ECF, Lidocaine, Class, Valid claim, CVS, State Administrative Expenses, Vexatious litigation, EST, CVS Pharmacy, Benefit, Person, Objection, La Belle et la Bête (opera), Plaintiff, Action Replay, Settlement, Proof of purchase, Documentation, District court, SKU, ECF, Hearing, Form, Court, Tobacco Master Settlement Agreement, Counsel, United States district court, Civil Rights Attorney's Fees Award Act of 1976, Cryptocurrency, Insurance

PHILADELPHIA, Aug. 22, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Max Strength CVS-Brand Lidocaine Settlement (Bell et.

Key Points: 
  • PHILADELPHIA, Aug. 22, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Max Strength CVS-Brand Lidocaine Settlement (Bell et.
  • "Products" means all CVS-branded "maximum strength" lidocaine patches, creams, roll-ons, and spray products, including, but not limited to, the products listed in the First Amended Complaint.
  • If the Product you bought was sold under the CVS brand and says "maximum strength" on the box, you may qualify as a Settlement Class Member.
  • The Settlement provides a maximum of up to $3,800,000.00 (the "Settlement Sum") to pay Valid Claims, Class Counsel's Fee Award, and Class Representative Service Awards.

TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF THE COMMON STOCK OF RESIDEO TECHNOLOGIES, INC. ("RESIDEO" OR THE "COMPANY") CURRENTLY AND AS OF FEBRUARY 13, 2023, EXCLUDING DEFENDANTS AND ANY ENTITY IN WHICH THEY HAVE A CONTROLLING INTEREST AND OFFICERS A

Retrieved on: 
Friday, March 10, 2023
Defendant, Notice, Judgement, Telephone, Episcopal conference, DE, Counsel, Corporate governance, In re Citigroup Inc. Shareholder Derivative Litigation, Seventh Avenue, Del, Derived demand, Civil Rights Attorney's Fees Award Act of 1976, Glades Road, District court, Exhibit A, Delaware Court, COMMON, Suite, Hearing, Motion, OF, Delaware Court of Chancery, Prejudice, Settlement, Plaintiff, Name, Pharmaceutical industry, Lease, Insurance, Court, Resideo

PHILADELPHIA, March 10, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Resideo Technologies Derivative Settlement.

Key Points: 
  • PHILADELPHIA, March 10, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Resideo Technologies Derivative Settlement.
  • A link to the text of the Stipulation and the full-length Notice of Pendency and Proposed Settlement of Shareholder Derivative Action may be found at www.ResideoTechnologiesDerivativeSettlement.com .
  • All capitalized terms herein have the same meanings as set forth in the Stipulation.
  • (the "Delaware Chancery Action"); and (2) a pending litigation demand made by Resideo stockholder Alice Burstein (the "Derivative Demand").

EMPLOYMENT LAW EXPERT ERIN PULASKI RELEASES TREATISE WITH PRACTISING LAW INSTITUTE

Retrieved on: 
Monday, October 31, 2022
Pulaski, Civil Rights Attorney's Fees Award Act of 1976, Practising Law Institute, Partner, Compliance, Labour, SAN, San Francisco (magazine), Woman, Chambers and Partners, LLP, PLI, National origin, Negotiation, Sexism, Chambers, Employment, Editing, Lowe, De Geer, Public relations, Property management

SAN FRANCISCO, Oct. 31, 2022 /PRNewswire/ -- Attorney Erin Pulaski, Partner at Rudy Exelrod Zieff & Lowe LLP (REZL), has released a new treatise through the Practising Law Institute (PLI). Ms. Pulaski served as Co-Editor alongside Greenberg Traurig LLP's Lindsay Hutner.

Key Points: 
  • Erin Pulaski, Partner of the San Francisco-based employment law firm Rudy, Exelrod, Zieff & Lowe, LLP, releases treatise delving into statutes and case law governing the employer-employee relationship in California.
  • SAN FRANCISCO, Oct. 31, 2022 /PRNewswire/ -- Attorney Erin Pulaski, Partner at Rudy Exelrod Zieff & Lowe LLP (REZL), has released a new treatise through the Practising Law Institute (PLI).
  • The treatise, California Employment Law, includes fourteen chapters providing practical guidance on state, local, and federal rules and regulations, and the intricacies of employment law as it pertains to a variety of topics including discrimination, workplace harassment, and whistleblower rights.
  • They were recently named a Band 1 Firm for Labor & Employment: Mainly Plaintiffs in California by Chambers & Partners .

Life sciences industry's highest achievers celebrated at prestigious Awards ceremony

Retrieved on: 
Thursday, October 27, 2022
Golodirsen, Johnson & Johnson, Growth, ANZ, Ecosystem, Murdoch University, Skin, Solution, Investment, Company, TGA, Radiopharmaceutical, Commer, Research, Achievement, USD, Food technology, Foundation, Neurology, Surgeon, FDA, PYC, Therapy, Patient, University, Multimedia, AUD, Health, Diagnosis, Biotechnology, Health Canada, Gynaecology, Map, Civil Rights Attorney's Fees Award Act of 1976, Innovation, Industry, COVID-19, Medical tourism, PSMA, Prostate cancer, Casimersen, Forrest, Molecular medicine, Biomedical Research, Ten Mile, Eteplirsen, Secondary research, University of Western Australia, Pathology, Otorhinolaryngology, Partnership, Sarepta Therapeutics, Leadership, Telescopic sight, Pharmaceutical industry, Medicine, Medical device, Renewable energy, Medical imaging, Telix

PERTH, Australia, Oct, 27, 2022 /PRNewswire/ -- Biotech's illustrious Industry Excellence Awards were announced today at the AusBiotech 2022 national conference in Perth – recognising outstanding contribution and achievement. The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards recognise innovative companies and individuals in Australia's world-class biotechnology, medical technology and healthcare sectors.

Key Points: 
  • The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards recognise innovative companies and individuals in Australia's world-class biotechnology, medical technology and healthcare sectors.
  • Dr Andrew Forrest AO and Nicola Forrest AO were also awarded the AusBiotech Life Sciences Legacy Award in recognition of their generous and active support of medical research and Australian life science innovation.
  • The discovery, development and commercialisation of biomedical research takes a global effort from diverse ecosystem including scientists, entrepreneurs, philanthropists and industry partners.
  • AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural sectors.